pharmacology overview Flashcards

1
Q

log kill hypothesis:

  1. doubling time of tumor assumed to be ______ regardless of tumor size
  2. fraction of cells killed with each cycle of therapy is constant through growth of tumors may be ____
  3. assumes __________sensitivity to therapy
A
  1. doubling time of tumor assumed to be constant regardless of tumor size
  2. fraction of cells killed with each cycle of therapy is constant through growth of tumors may be exponential
  3. assumes homogeneous sensitivity to therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Goldie-Coldman hypothesis:

  1. takes into account property of drug _______
  2. proposes that best strategy for treatment is to
  3. goals is prevention of tumor__________
A
  1. takes into account property of drug resistance
  2. proposes that best strategy for treatment is to initiate therapy early (small tumor) with combinations of active drugs
  3. goals is prevention of tumor resistance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

types of treatment (5)

A
  1. single
  2. sequential
  3. combination
  4. immunotherapy
  5. Hormonal therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

liquid tumors types of therapy (3)

A
  1. induction
  2. consolidation
  3. maintenance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

solid tumors types of therapy (3)

A
  1. adjuvant therapy
  2. neoadjuvant therapy
  3. palliation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

intial treatment to get patient into complete remission

A

induction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

used in leukemia to eradicate micrometastatic disease

A

consolidation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

prolonged therapy; often used in ALL

A

maintenance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

used after definitive solid surgery to eradicate micro-metastatic disease

A

adjuvant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

used to reduce tumor burden prior surgical intervention

A

neoadjuvant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

used to reduce symptoms and improve quality of life

A

palliative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

disappearance of all evidence of tumor

A

complete response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

decrease of at least 50% in diameter of all measurable lesions

A

partial response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

decrease of less than 50% to increase of less than 25% in diameter product of lesion

A

stable disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

increase of more than 25% in diameter product of any lesion

A

progressive disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

there are many factors that might affect response to therapy

A

yep, such as tumor burden, diagnosis, stage/grade, tumor cell heterogeneity, drug resistance such as in AML in elderly, and diseases like Fanconi that are mores susceptible to adverse SE of chemo due to chromosome fragility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

medical therapies for cancer are often administered according to a schedule based on ____ why?

A

cycles . after chemo is given there is usually a “rest period” during which no treatment is given, allowing normal cells to recover from chemo effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

affect microtubule formation and work in M-phase

A

vinca alkaloids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

are incorporated as false analogues in DNA and RNA synthesis and work in S-phase

A

anti-metabolites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

cell cycle non-specific therapies include (2) meaning that they occur independently of phase in which the cycle is occurring

A
  1. alkylating agents

2. anti-tumor antibiotics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

form inter- and intra- strand crosslinks in DNA

A

alkylating agents

22
Q

intercalate into DNA

A

anti-tumor antibiotics

23
Q

exert their effects through binding a particular molecular on the cell surface

A

monoclonal ab

24
Q

exert their effects through manipulation of the immune system

A

biologic agents

25
Q

the vomiting center is in the

A

medulla

26
Q

the chemoreceptor trigger zone which sens info to the vomiting center is found in the

A

fourth ventricle

27
Q

vagal and sympathetic afferents from GI tract stimulate

A

vomiting center and chemoreceptor trigger zone

28
Q

serotonin is released from

A

enterochromaffin cells in GI tract

29
Q

ACUTE chemotherapy-induced nausea and vomiting:

  1. occurs in the ____ hr after chemo
  2. peaks _____ hr after start of infusion
  3. typical drugs used to treat include
A
  1. occurs in the first 24 hr after chemo
  2. peaks 3-4 hr after start of infusion
  3. typical drugs used to treat include serotonin antagonists, corticosteroids and dopamine antagonists
30
Q

DELAYED chemotherapy-induced nausea and vomiting:

  1. occurs after the ____ hr of chemo
  2. it can lasts for ___days and typically peaks ____ days after infusion
  3. associated with specific chemo agents-
  4. drugs used for the prophylaxis and treatment of delayed N/V include
A
  1. occurs after the first 24 hr of chemo
  2. it can lasts for 3-5 and typically peaks 2-3 days after infusion
  3. associated with specific chemo agents- cisplatin, cyclophosphamide and doxorubicin
  4. drugs used for the prophylaxis and treatment of delayed N/V include serotonin antagonists, NK-1 antagonists, corticosteroids, dopamine antagonists
31
Q

ANTICIPATORY chemotherapy-induced nausea and vomiting

  1. response is _______ occurring before chemo is administered
  2. best treated prophylactivally with
A
  1. response if conditioned occurring before chemo is administered
  2. best treated prophylactivally with benzodiazepines
32
Q

Serotonin antagonists:

  1. block the action of serotonin in the periphery and at the CTZ at the _______
  2. major side effects include (3)
  3. high doses are associated with this ekg abnormality-
  4. examples include (2)
A
  1. block the action of serotonin in the periphery and at the CTZ at the type 3 receptor
  2. major side effects include headache, hiccups and constipation
  3. high doses are associated with this ekg abnormality- QTc prolongation
  4. examples include ondansetron and palonosetron
33
Q

difference between ondansetron aand palonosetron

A

ondansetron needs to be given at least one time per day while palonosetron has a long half life and thus only needs a one time IV dose

34
Q

NK-1 antagonists

  1. block the substance ___at the neurokinin-1 reception in the CNS and the periphery
  2. indicated in the treatment(2)
  3. major SE include (2)
  4. multiple drug interactions to ____system leading to a decrease in the efficacy of (2), and increasing the serum concentration of (1)
  5. example includes
A
  1. block the substance P at the neurokinin-1 reception in the CNS and the periphery
  2. indicated in the treatment of both acute and delayed N/V
  3. major SE include fatigue, hiccups.
  4. multiple drug interactions due to the effects on the p450 system leading to a decrease in the efficacy of oral contraceptives and warfarin, and increasing the serum concentration of corticosteroids
  5. example includes aprepitant
35
Q

corticosteroids:

  1. mechanism is
  2. major SE include (4)
  3. it increases the
  4. example is (1)
A
  1. mechanism is unknown- anti-emetic
  2. major SE include glucose intolerance, HTN, insomnia and agitation/jitteriness
  3. it increases the efficacy of other drugs by 20%
  4. example is dexamethasone
36
Q

Olanzapine

  1. it is considered to be
  2. mechanism of action is that it modulates ____ and _____ activity
  3. it is used more in
A
  1. it is considered to be a atypical antipsychotic
  2. mechanism of action is that it modulates central dopaminergic and serotonergic activity
  3. it is used more in acute vs delayed CINV
37
Q

Dopamine antagonists:

  1. blocks D1 and D2 receptors in (2)
  2. indicated for the treatment of
  3. major toxicities of dopamine antagonists include (2)
  4. examples include (2)
  5. mild toxicities of these drugs can be treated with (2)
  6. often used for
A
  1. blocks D1 and D2 receptors in CTZ and peripherally
  2. indicated for the treatment of acute and delayed N/V
  3. major toxicities of dopamine antagonists include extrapyramidal side effects (EPS) and akathisia.
  4. examples include prochloreperazine and metoclopramide
  5. mild toxicities of these drugs can be treated with diphenhydramine or benztropine
  6. often used for breakthrough (prn)
38
Q

benzodiazepines:

  1. acts on (3)
  2. action is mediated via ___
  3. side effects include (2)
  4. often used for
A
  1. acts on limbic, thalamic and hypothalamic areas of CNS
  2. action is mediated via GABA
  3. side effects include sedation, retrograde amnesia
  4. often used for breakthrough (prn)
39
Q

chemo can result in the suppression of psecific hematopoietic cell lines or all three leading to cytopenias

A

yep

40
Q

glycoproteins produced by recombinant DNA technology that mimic endogenous erythropoetin, triggering the bone marrow to produce RBCs

A

Erythropoietin stimulating agents

41
Q

how many people respond to ESAs

A

30-50% of patients with chemo induced anemia respond

42
Q

all patients receiving ESAs should have iron studies performed before being started on the drugs… why?

A

adequate iron stores are required for these agents to work

43
Q

Side effects of ESAs include (3)

A
  1. HTN
  2. arthralagias
  3. rash
44
Q

a neutropenia with an absolute neutrophil count (ANC) of less than 500 found that risk of infection is related to severity and duration of neutropenia

A

yep

45
Q

what is used to lessen the depth and length of neutropenia and enhances proliferation and differentiation of myeloid cell lines and function of the cell that they stimulate

A

myeloid growth factors

46
Q

adverse effects of myeloid growth factors (4)

A
  1. fever
  2. bone pain
  3. increases in uric acid, LDH and alkaline phosphatase which represent cells turning over
  4. splenic infarct which is rare
47
Q

myeloid growth factors are indicated:

  1. primary prophylaxis:
  2. secondary prophylaxis:
  3. established neutropenia:
A
  1. primary prophylaxis: for regiments know to cause neutropenia
  2. secondary prophylaxis: curative intent; maintain dosse density
  3. established neutropenia: febrile neutropenia is reduced by 1-3 days
48
Q

long acting formulation of G-CSF which is dosed once after chemo; the clearance is via neutrophil mediated endocytosis and degradation and is thus auto-regulated as the neutrophil count recovers

A

Neulasta

49
Q

2 forms of myeloid growth factors

A
  1. granulocyte colony stimulating factor used to enhance proliferation and differentiation of neutrophils
  2. granulocyte macrophage colony stimulating factor used to enhance proliferation and differentiation of granulocytes and macrophages
50
Q

filgrastim

A

granulocyte colony stimulating factor used to enhance proliferation and differentiation of neutrophils

51
Q

sargramostim

A

granulocyte macrophage colony stimulating factor used to enhance proliferation and differentiation of granulocytes and macrophages